Surgical Management of Failed First Metatarsophalangeal Joint Arthroplasty.

Cartiva Failed MTP joint arthroplasty Failed cartiva MTP arthrodesis MTP joint Metatarsophalangeal joint arthrodesis Metatarsophalangeal joint arthroplasty

Journal

Foot and ankle clinics
ISSN: 1558-1934
Titre abrégé: Foot Ankle Clin
Pays: United States
ID NLM: 9615073

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 28 7 2024
pubmed: 28 7 2024
entrez: 27 7 2024
Statut: ppublish

Résumé

This article describes the etiology, clinical presentation, surgical management, and outcomes for treatment of the failed first metatarsophalangeal (MTP) joint arthroplasty. Failure following implant arthroplasty typically creates large osseous deficits and surgical management can be difficult. Salvage arthrodesis provides reliable joint stability while maintaining hallux length. Outcomes following conversion of a failed MTP joint arthroplasty to MTP joint arthrodesis have demonstrated consistent pain relief and high satisfaction: however, high rates of complication and nonunion have been reported. Bone graft may be necessary to fill large voids in the joint. Other revision options for failed arthroplasty have been described, but outcomes remain inconsistent and varied. Ultimately, conversion to MTP joint arthrodesis is the recommended intervention for treatment of the failed MTP arthroplasty implant, providing sufficient stability and pain relief.

Identifiants

pubmed: 39068028
pii: S1083-7515(23)00323-6
doi: 10.1016/j.fcl.2023.12.009
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

541-556

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure M.E. Easley: Exactech, Inc: IP royalties; Paid consultant; Paid presenter or speaker; Research support. IFFAS: Board or committee member. Journal of Bone and Joint Surgery - American: Editorial or governing board. Paragon28: Paid consultant; Paid presenter or speaker. Saunders/Mosby-Elsevier: Publishing royalties, financial or material support. Springer: Publishing royalties, financial or material support. Treace Medical: IP royalties; Paid consultant; Paid presenter or speaker. Wolters Kluwer Health - Lippincott Williams & Wilkins: Publishing royalties, financial or material support. A.T. Anastasio: QPIX Solutions – Paid consultant. I. Shaffrey has nothing to disclose.

Auteurs

Albert T Anastasio (AT)

Department of Orthopaedics, Duke University Hospital, Durham, NC, USA. Electronic address: Albert.anastasio@duke.edu.

Isabel Shaffrey (I)

Duke University School of Medicine, 2927 40 Duke Medicine Circle 124 Davison Building, Durham, NC 27710, USA.

Mark E Easley (ME)

Department of Orthopaedics, Duke University Hospital, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH